Friday, November 28, 2014

Cellceutix’s potential breakthrough in cancer research

Cellceutix’s potential breakthrough in cancer research

November 22, 2011 by · 1 Comment 

Tweet Cellceutix (OTCBB:CTIX) of Beverly, Mass. believes it has found the Holy Grail in cancer research: a compound that activates a tumor suppressor protein known as p53, long regarded as possibly holding the key to future cancer therapies. “Our Kevetrin drug reactivates p53 to its normal function of dictating whether to fix the cell or […]

Email Newsletters with Constant Contact
Google+